Dr. Kave Moloudi | Oxidative stress | Research Excellence Award 

Caen-Normandy University, France

Dr. Kave Moloudi is an internationally recognized scientist specializing in nanotheranostics, radiobiology, photodynamic therapy, and cancer nanomedicine. His academic and research activities focus on integrating nanotechnology with biomedical sciences to develop innovative therapeutic and diagnostic solutions for cancer treatment. Through extensive interdisciplinary collaborations, Dr. Moloudi has contributed to significant advancements in nanoparticle-based drug delivery systems, molecular imaging, radiotherapy enhancement, and tumor-targeted therapies. His strong publication profile, high citation count, and impactful scientific reviews demonstrate his growing influence within the global biomedical research community. He has collaborated with prominent researchers and institutions across multiple countries, strengthening international scientific partnerships and knowledge exchange. Dr. Moloudi’s work reflects originality, technical expertise, and dedication to improving translational cancer therapies through innovative biomedical technologies. His contributions to oncology and nanomedicine research continue to gain academic recognition, establishing him as a respected and promising researcher committed to advancing modern healthcare science and therapeutic innovation worldwide.

Professional Profile

• Google Scholar

Education

Dr. Kave Moloudi has developed a strong academic foundation in biomedical sciences, nanotechnology, radiobiology, and cancer therapy through advanced education and specialized scientific training. His educational journey reflects a deep commitment to interdisciplinary learning, combining principles of medicine, molecular biology, physics, and nanoscience to address complex healthcare challenges. Through academic research and technical coursework, he gained expertise in photodynamic therapy, nanoparticle engineering, imaging technologies, and therapeutic innovation. His educational background prepared him to conduct high-quality translational research and contribute to emerging areas of nanomedicine and oncology. Throughout his studies, Dr. Moloudi demonstrated analytical thinking, scientific curiosity, and dedication to advancing biomedical knowledge. His academic preparation also enabled him to collaborate effectively with international researchers and contribute to peer-reviewed scientific literature. The combination of theoretical knowledge and practical research experience has positioned him as a capable scientist actively supporting innovation in cancer treatment and modern biomedical technologies.

Professional Experience

Dr. Kave Moloudi possesses extensive research experience in nanomedicine, radiobiology, molecular imaging, and photodynamic cancer therapy. His professional activities involve interdisciplinary scientific investigations focused on improving therapeutic efficiency and advancing innovative biomedical applications. Through affiliations with international research institutions and universities, he has contributed to collaborative projects addressing cancer treatment strategies, nanoparticle-mediated therapies, and translational medicine. Dr. Moloudi has actively participated in experimental research, publication development, and scientific communication within the biomedical and oncology communities. His experience includes working alongside researchers from medical sciences, nanotechnology, and molecular medicine backgrounds, strengthening his multidisciplinary expertise. He has also contributed to reviews and investigations exploring therapeutic enhancement, tumor targeting, and advanced drug delivery systems. Through continuous involvement in scientific innovation and collaborative research environments, Dr. Moloudi has built a respected academic profile characterized by technical competence, research productivity, and dedication to improving healthcare technologies and biomedical treatment methodologies.

Research Interest

Dr. Kave Moloudi’s research interests focus on nanotheranostics, photodynamic therapy, cancer nanomedicine, radiobiology, molecular imaging, and advanced therapeutic technologies. His scientific investigations aim to improve cancer diagnosis and treatment using nanoparticle-based drug delivery systems, radiosensitizers, and innovative biomedical materials. He is particularly interested in enhancing the effectiveness of radiotherapy and photodynamic therapy while minimizing side effects associated with conventional cancer treatments. Dr. Moloudi also explores the biological interactions of nanoparticles, tumor microenvironment modulation, fluorescence imaging, and targeted therapeutic strategies for oncology applications. His work integrates nanotechnology, molecular medicine, and biomedical engineering to develop translational healthcare solutions with clinical relevance. Additionally, his research addresses immune modulation, apoptosis induction, and combination therapies designed to optimize treatment outcomes in cancer patients. Through interdisciplinary collaboration and innovative scientific approaches, Dr. Moloudi continues contributing to the advancement of personalized medicine, biomedical innovation, and next-generation cancer therapeutics.

Award and Honor

Dr. Kave Moloudi has gained substantial academic recognition through his influential research publications, strong citation record, and growing international scientific reputation in biomedical and nanomedicine research. His scholarly impact is demonstrated by a high h-index and numerous widely cited articles in respected journals related to oncology, nanotechnology, and molecular medicine. These achievements reflect the scientific community’s acknowledgment of his innovative contributions to cancer therapy and biomedical applications. His collaborations with internationally recognized researchers and institutions further highlight his professional credibility and research excellence. Dr. Moloudi’s work on photodynamic therapy, nanoparticle-based treatments, and radiobiology has attracted considerable academic attention and established him as a valuable contributor to modern healthcare research. Although formal public award listings may be limited, his publication achievements, citation influence, and interdisciplinary scientific advancements serve as indicators of distinction and professional accomplishment within the global biomedical and cancer research communities.

Conclusion